Real-time enrollment status for this myeloid malignancy clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 3:18 PM UTC
| NCT Number | NCT07044544 |
| Recruiting Status | Recruiting |
| Condition | Myeloid Malignancy |
| Phase | PHASE1 |
| Target Enrollment | 20 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Alabama at Birmingham |
| Last Updated on CT.gov | March 4, 2026 (Mar 4, 2026) |
As of October 15, 2026: Clinical trial NCT07044544 is currently recruiting participants. This phase1 study for myeloid malignancy is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Alabama at Birmingham. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07044544 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07044544 was last updated Mar 4, 2026 (March 4, 2026). HelloStudys verifies this status automatically.